Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lycium chinense fruit extract (LFE) is a botanical extract derived from the fruit of *Lycium chinense* Miller, commonly known as Chinese Wolfberry. It is a complex mixture rich in polysaccharides, antioxidants, amino acids, and vitamins. LFE has been investigated in clinical settings for its hepatoprotective effects, specifically its ability to reduce liver enzyme levels such as alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) in individuals with mild hepatic dysfunction. Additionally, research has explored its potential to enhance cognitive functions, including attention, in healthy adults. Preclinical studies have also suggested neuroprotective properties in models of Alzheimer's disease, with proposed mechanisms involving the modulation of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) signaling pathways. Beyond its therapeutic investigations, it is widely used as a cosmetic ingredient for its antioxidant and skin-soothing properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lycium chinense fruit extract.